3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Classical hematology
2
Myeloid
1
Conditions
Myelodysplastic Syndromes
30
Leukemia, Myeloid, Acute
22
Myeloproliferative Disorders
15
Leukemia, Myelomonocytic, Chronic
13
Myelodysplastic-Myeloproliferative Diseases
9
Primary Myelofibrosis
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Non-Hodgkin
6
Polycythemia Vera
5
Neuroblastoma
5
Leukemia
5
Histiocytosis, Langerhans-Cell
5
Wilms Tumor
4
Thrombocythemia, Essential
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Multiple Myeloma
4
Medulloblastoma
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Central Nervous System Neoplasms
4
Anemia
4
Thrombocytosis
3
Sarcoma
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Interventions
AP 1903 reagent
3
ON 01910
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
cedazuridine
1
Therapeutics
1
Sertraline
1
Peripheral Blood Stem Cell Transplantation
1
Interleukin-8
1
IDO-1 inhibitor LY3381916
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Exercise
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Biopsy
×
Myeloid
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled